SCHEMBL29947205

SCHEMBL29947205

Nc1cccc(F)c1N1CCC(Oc2ccc(C(F)(F)F)cn2)CC1

nearest known ligand 0.49

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
LIPE Q05469 8/20 0.49
LIPG Q9Y5X9 1/20 0.48
HCRTR1 O43613 8/20 0.45
HCRTR2 O43614 5/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29947133 0.83 POLB (0.49) LIPELIPGHCRTR1HCRTR2
SCHEMBL29947145 0.81 PDE3B (0.41)
SCHEMBL23708283 0.80 LIPG (0.60) LIPELIPGHCRTR1HCRTR2
SCHEMBL29995288 0.80 LIPG (0.60) LIPELIPGHCRTR1HCRTR2
SCHEMBL23702791 0.80 LIPG (0.60) LIPELIPGHCRTR1HCRTR2
SCHEMBL29995239 0.80 LIPG (0.60) LIPELIPGHCRTR1HCRTR2
SCHEMBL26620485 0.80 LIPG (0.60) LIPELIPGHCRTR1HCRTR2
SCHEMBL23702751 0.79 LIPG (0.62) LIPELIPGHCRTR1HCRTR2
SCHEMBL23703427 0.79 LIPG (0.62) LIPELIPGHCRTR1HCRTR2
SCHEMBL23708114 0.79 LIPG (0.62) LIPELIPGHCRTR1HCRTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4337206-A1 HETEROCYCLIC TRPML1 AGONISTS AND USES THEREOF Libra Therapeutics, Inc. (US) 2024-03-20 EP disclosed
WO-2022240992-A1 HETEROCYCLIC TRPML1 AGONISTS AND USES THEREOF LIBRA THERAPEUTICS, INC. (US) 2022-11-17 WO disclosed